Welcome to our dedicated page for Akamai Technologies SEC filings (Ticker: AKAM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Akamai Technologies, Inc. (NASDAQ: AKAM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a public issuer with common stock listed on the Nasdaq Global Select Market. Recent Form 8-K filings confirm that Akamai’s common stock, with a par value of $0.01 per share, trades under the symbol AKAM and is registered pursuant to Section 12(b) of the Securities Exchange Act of 1934.
Current reports on Form 8-K document material events such as quarterly financial results, product launches, and corporate governance updates. For example, Akamai has furnished press releases announcing financial results for quarters ended June 30 and September 30, 2025 under Item 2.02 (Results of Operations and Financial Condition. Other 8-K filings describe the launch of Akamai Inference Cloud under Item 7.01 (Regulation FD Disclosure) and the election of new members to the Board of Directors under Item 5.02.
Filings also capture insider-related and capital markets information. One Form 8-K notes open-market purchases of Akamai common stock by the company’s chief executive officer and the chair of its board, including details on share counts and weighted average purchase prices. These disclosures help investors track insider activity and governance developments alongside operational news.
In addition to 8-Ks, investors typically consult Akamai’s annual reports on Form 10-K, quarterly reports on Form 10-Q, and any proxy statements for information on business risks, segment performance, executive compensation, and corporate governance, as filed with the SEC. On Stock Titan, AI-powered tools can assist by summarizing lengthy filings, highlighting key sections in 10-K and 10-Q reports, and making it easier to interpret complex disclosures.
As Akamai continues to report on security, delivery, and cloud computing activities, this filings page serves as a centralized view of its official SEC documents, including real-time updates from EDGAR and convenient access to current reports, periodic reports, and insider-related disclosures.
Akamai Technologies, Inc. furnished a Form 8-K under Regulation FD to announce the launch of Akamai Inference Cloud, a platform enabling AI inferencing at the edge of the internet.
The related press release is furnished as Exhibit 99.1 and incorporated by reference. The announcement was made on October 28, 2025.
Akamai Technologies, Inc. (AKAM) Form 144 notice reports a proposed sale of 5,000 shares of common stock through Charles Schwab & Co., Inc. on 09/15/2025 on NASDAQ with an aggregate market value listed as $383,234.00.
The shares were originally acquired as RSU/PSU from Akamai on 02/21/2024 as equity compensation. The filer also reports a prior sale of 5,000 shares on 07/15/2025 generating gross proceeds of $388,700.00. The notice includes the required representation that the seller has no undisclosed material adverse information and references Rule 10b5-1 plan language if applicable.
Akamai Technologies officer Laura Howell reported transactions in company common stock on 09/06/2025. She surrendered 33 restricted stock units (RSUs) which converted into 33 shares and reported two dispositions of common stock: one labeled code M for 33 shares (RSU settlement) and one labeled code F selling 10 shares at $78.56 per share, leaving her with 20,884 shares owned directly after the reported sale. The filing also discloses she beneficially owned 109,646 shares indirectly through a 401(k) plan as of 09/05/2025. The RSUs were originally granted on 12/06/2022 and vest over three years under the stated schedule.
Robert Blumofe, Chief Technology Officer at Akamai Technologies (AKAM), reported an insider sale on Form 4. On 08/22/2025 he disposed of 3,000 shares of Akamai common stock at a price of $77 per share. Following the reported transaction he is shown as beneficially owning 27,910 shares directly. The filing also records an indirect interest described as "64.184(2) I By 401(k) Plan" with a date of record as of August 21, 2025. The sale was made under a Rule 10b5-1 trading plan adopted by Dr. Blumofe on March 12, 2025. The Form 4 was signed by Thomas M. Lair as attorney-in-fact on 08/22/2025.
Akamai Technologies, Inc. (AKAM) Form 144 shows a proposed sale of 3,000 common shares through Charles Schwab & Co., with an aggregate market value of $231,000 and an approximate sale date of 08/22/2025. The filing reports total shares outstanding of 143,385,528. The 3,000 shares to be sold were acquired through restricted stock lapses on 02/21/2025 (220 shares), 03/04/2025 (1,725 shares), and 03/06/2025 (1,055 shares), and payment was made as equity compensation. The filing also discloses a separate sale during the past three months: 3,254 shares sold by Robert Blumofe on 06/12/2025 for gross proceeds of $253,714. The notice includes the standard insider representation regarding material nonpublic information.
Akamai Technologies insider sale by EVP & General Counsel. On 08/20/2025 Aaron Ahola, EVP & General Counsel of Akamai Technologies (AKAM), reported disposal of 4,000 shares of Common Stock in a transaction coded "S" at a weighted average price of $75.76. Following the reported sale the filing shows 21,211 shares beneficially owned, which the filer notes includes 2,930 shares deferred under the companys non-qualified deferred compensation plan and additional shares held in the Aaron Ahola Revocable Trust where he serves as trustee. The form also lists a line for Common Stock with the notation "104.562(4) I By 401(k) Plan" and cites that figure as of August 19, 2025. The Form 4 was signed via power of attorney.
Akamai Technologies, Inc. (AKAM) Form 144 shows a proposed insider sale of 4,000 common shares via Charles Schwab & Co., with an aggregate market value of $303,040. The filing lists total outstanding shares of 143,385,528 and an approximate sale date of 08/20/2025. The 4,000 shares were acquired through equity compensation: 2,476 shares from a performance stock lapse on 02/19/2025 and 1,524 shares from a restricted stock lapse on 03/06/2025. No sales in the past three months are reported and the filer certifies no undisclosed material adverse information.
Akamai Technologies (AKAM) insider activity centers on trusts linked to its CEO. On August 11, 2025, the F. Thomson Leighton and Bonnie B. Leighton Revocable Trust, for which CEO F. Thomson Leighton serves as trustee, made two open‑market purchases of Akamai common stock: 2,076 shares at a weighted‑average price of $71.3315 and 47,924 shares at a weighted‑average price of $72.3012.
Following these transactions, the revocable trust indirectly held 2,430,291 shares, which includes 10,481 shares received from a distribution by the David T. Leighton trust. Leighton disclaims beneficial ownership of the revocable trust’s shares except to the extent of his pecuniary interest. Separately, he directly holds 127,967 shares, and 108,358 shares are held by the TBL Foundation, where he also serves as trustee.
Daniel Hesse, a director of Akamai Technologies, reported the purchase of 3,000 shares of Akamai common stock on 08/11/2025 at a weighted-average price of $72.299. The filing notes the shares were acquired in multiple transactions with prices ranging from $72.05 to $72.72 and offers to provide per-trade detail on request.
Following the purchases, Mr. Hesse beneficially owned 21,387 shares on a direct basis. The Form 4 discloses only non-derivative purchases and includes a power-of-attorney signature; no dispositions or derivative transactions are reported in this filing.
Akamai Technologies, Inc. disclosed that two senior insiders bought company stock in open-market transactions. Chief Executive Officer F. Thomson Leighton purchased 50,000 shares at a weighted average price of $72.2609 per share, and Board Chair Daniel Hesse purchased 3,000 shares at a weighted average price of $72.2990 per share. The disclosure was filed under Regulation FD to inform investors of these insider purchases. The filing contains only the purchase amounts and prices and does not include any commentary on motive, change in ownership percentage, or additional transactions.